Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
E-COMmerce Proficient Analytics in Security and Sales for SMEs (SME E-COMPASS)

Framework: FP7 — Capacities
Programme: Research for the benefit of SMEs
Destination: Research for SME associations
Action type: Research for the benefit of specific groups
Countries involved: Greece,Spain,Germany,Spain,United Kingdom,Spain,Germany,Spain,Lithuania
Call:  (FP7-SME-2012, 2012)
Start date: 2014-01-01
End date: 2015-12-31
Duration (months): 24.0
Total project cost (EUR): 2392443.19
EU funding (EUR): 1679700.0
Participants: 13
Project status: CLOSED

The SME E-COMPASS project offers real-time and on-demand web-based applications and services to SME e-commerce providers that they could not afford or do not have the business capacity for ordering customized applications from large IT and software providers. In an attempt to overcome time and scale limitations in these complex market conditions and threats for SME e-commerce providers, the SME E-COMPASS consortium proposes to design, develop and validate in SME business environments two real-time proficient applications that fosters online security and promotes e-sales , namely : 1) Real-time Anti-fraud “Software-as-a-Service” with the following components: fully-functional web-based platform, a reputation database, a knowledge database (KDB). 2) Real-time Data Mining “Software-as-a-Service powered by: semantic web technologies, linked data, an event processing engine and web-based visualizations and dashboards. Real-time anti-fraud aims at detecting fraud by analyzing financial transactions. Banks, retailers, credit card companies, telecommunications firms and many other organizations wrestle with this issue. The proposed anti-fraud service scores fraud predicting outcomes using data mining models. Transactions are analyzed as they occur within customer accounts. Once the normal mode of operations is understood capturing all previous transactions, unusual patterns and suspicious transactions are recognized. As the scoring model is limited by the memory and processing power of the machine on which it runs, the SaaS (Software as a Service) paradigm helps handling the massive computational requirements associated with analyzing customer purchasing patterns. The proposed platform can rapidly predict behavior at the transactional level and be part of an enterprise application for real-time predictions bringing Enterprise Real-time Analysis to SME. Besides real-time anti-fraud, another key issue to promote e-sales is to have proficient services for real-time data mining in order to improve conversion rates and sales. These services are based on: • User habits, available products and services, and social reputation. • Pricing optimization and yield management for perishable resources. SME merchants will be provided with a web based engagement services and a dashboard to define rules for cross-selling and pricing, backed by a complex event processing engine and a data warehouse to fulfill real-time requirements.

Keywords: antifraud,online,saas,price optimization,data mining,hybrid methods,real time,semantic web,computational intelligent
Specialised Cell Carrier Components (SPECCC)

Framework: FP7 — Capacities
Programme: Research for the benefit of SMEs
Destination: Research for SMEs
Action type: Research for the benefit of specific groups
Countries involved: Portugal,Ireland,Luxembourg,Ireland,Germany,United Kingdom
Call:  (FP7-SME-2012, 2012)
Start date: 2012-11-01
End date: 2020-10-31
Duration (months): 96.0
Total project cost (EUR): 1425790.0
EU funding (EUR): 1065574.0
Participants: 8
Project status: CLOSED

Silicone offers significant advantages as a 3D cell scaffold, essentially a 3D microtissue device. These benefits include a capacity for variable porosity, variable open pore volume for cell entrapment, variable density for fluidisation, variable geometry, friction resistance, and low toxicity. The lead SME partner Cellon SA holds the IP for porous silicone carriers (Immobasil), which met some of these criteria, but exhibited poor cell adherence and requires re-engineering and exploitation of current cell biology knowledge and applications. There is a strong commercial need for such fully functional 3D cell culture technologies (microtissue) that can be manufactured into robust and reproducible in vitro test systems for toxicity testing, drug testing, cosmetic testing as part of a projected €1.6b cell based test market. This technology developed maybe suitable as an active component in bioartificial livers (BAL) and other bioartificial organ devices. The market growth is driven by needs in drug screening for drug discovery and toxicity screening. There are also a number of current EU directives that is driving the demand for reliable in vitro 3D cell based test system to replace in vivo test systems. The bio artificial liver market is also expected to grow rapidly due to high rates of liver disease worldwide. The objectives will be to deliver: 1) Immortalised hepatocyte and endothelial cells that retain characteristics of primary liver cells in 3D co-culture. 2) An improved porous silicone carrier for 3D culture of these cells (cell-carrier component) 3) A prototype fluidized bioreactor bed for culture of these cell carrier components. 4) Cell carrier component tested in a microwell plate The results of this project could form the basis for subsequent (following the completion of the SpeCCC project) commercial development as follows 1) 3D liver cell multiwell plate assay system, 2) 3D liver microbioreactor system and 3) a bioreactor component for a BAL device. Minimal SME economic return is predicted at €12m within 3 years of project completion.

Keywords: cell carrier,toxicity test,co culture,liver model
Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies (CELLEUROPE)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Initial Training Networks
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: United Kingdom,Norway,Germany,Germany,Austria,Czechia,Germany,Germany,Germany
Call:  (FP7-PEOPLE-2012-ITN, 2012)
Start date: 2012-10-01
End date: 2016-09-30
Duration (months): 48.0
Total project cost (EUR): 3226319.0
EU funding (EUR): 3226319.0
Participants: 11
Project status: CLOSED

Novel transplant regimens are currently being developed to improve beneficial GvL effects and reduce GvHD and infections via several new forms of cellular therapies. This newly emerging supra-disciplinary field of cellular therapy and regenerative medicine is also being used to improve outcomes in autoimmune disease (such as Rheumatoid Arthritis) and cancers. The goal of this research programme is to gain insight into the mechanisms of action of GvL and GvHD in order to improve current therapies and develop and test novel ones via clinical trials and/or animal model experiments. The research is therefore necessarily multidisciplinary including clinical medicine, immunology, genomics, proteomics, molecular biology and pathology. In order to implement cellular therapies across Europe the current EU Directive 2001/83/EC applies. These regulations stipulate that the cellular therapies which are advanced therapeutic medical products (ATMP) must be produced under current Good Manufacturing Practice (cGMP). Not only is there a lack of understanding of GvL vs. GvHD effects but there is also a lack of training in cGMP for both clinical and non-clinical scientists. We aim to re-address these basic current needs, as well as those of industry, which include lack of access to clinical tissue for validation of bio-markers prior to commercialisation.

Keywords: l606 immunogenetics,l101 molecular biology and interactions,l202 transcriptomics,l203 proteomics,l612 biological basis of immunity related disorders
Careers in Sustainability Excellence (CASTLE)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Initial Training Networks
Action type: Support for training and career development of researchers (Marie Curie)
Countries involved: Finland,Sweden,Germany,Finland,Germany,Austria,France,Austria
Call:  (FP7-PEOPLE-2012-ITN, 2012)
Start date: 2012-11-01
End date: 2016-10-31
Duration (months): 48.0
Total project cost (EUR): 3825383.54
EU funding (EUR): 3825383.54
Participants: 10
Project status: CLOSED

Implementing the EU vision of a Green Economy will cause rapid changes to the forest-based and bio-energy sectors. Growing bioenergy demands change land use and cause intensified resource utilisation in agriculture and forestry. Sustainable development targets in production and consumption of biomass and wood products have stimulated wider adoption of sustainability assessment methods in policy and company practices. The forest-based and bioenergy sectors have prominent roles to play in developing a sustainable knowledge based bio-economy due to their foundation on renewable resource use and their substantial climate change mitigation potential. The Careers in Sustainability Excellence (CASTLE) project will combine research and training on a suit of methods used for sustainability assessments in the forest-based and bioenergy sectors in Europe. The project will develop state-of-the art methods that can be applied to current sustainability challenges in the industry and regional policy making. The sustainability experts working in the sectors in the future need to be knowledgeable about direct sustainability impacts of operations (e.g. GHG-emissions, carbon footprint, and the resulting product footprints). But as new products may also induce indirect-land use changes especially in other world regions, the experts need to have a broad understanding of global market and land use effects. As communicators towards the customers, the future experts also need to transparently report on social corporate responsibility of companies. CASTLE will elaborate an overall training schedule on sustainability assessment methods to train the early stage researchers in a broad range of methods and skills that will offer them excellent competences for their future careers in the industry, consultancy business or policy making. 14 individual research studies will in addition develop specific methods and practices in more detail, mostly in cooperation with private sector actors.

Keywords: sustainability impact assessment,life cycle assessment,carbon accounting,product footprints,forest-wood chain,bioenergy,land use change
Strengthening the Research Potential of IMGGE through Reinforcement of Biomedical Science of Rare Diseases in Serbia – en route for innovation (SERBORDISINN)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Serbia
Call:  (FP7-REGPOT-2012-2013-1, 2012)
Start date: 2013-07-01
End date: 2016-06-30
Duration (months): 36.0
Total project cost (EUR): 2160440.0
EU funding (EUR): 1954819.0
Participants: 1
Project status: CLOSED

SERBORDISinn will enable IMGGE to become the most recognizable molecular genetic (MG) centre in the Balkans. IMGGE is the leading Serbian MG research institution, employing scientists with the highest expertise in molecular biology and molecular genetics. Research in the field of biomedical science of rare diseases (RD) is a major interest of IMGGE’s Laboratory for Molecular Hematology, Laboratory for Molecular Biology, Laboratory for Human Molecular Genetics and Laboratory for Molecular Genetics of Industrial Microorganisms. EU partnering organizations and EU experts, well known for their excellence in the topics related to SERBORDISinn, will be actively involved in the realization of the Project. Consequently, exchange of expertise and experience related to RD would intensify the transfer of knowledge from distinguished EU centers to IMGGE, enabling the implementation of cutting-edge MG approaches for the study of molecular markers of RD. Furthermore, SERBORDISinn will reinforce the establishment of Serbian and Balkan RD-specific databases and biobanks. Building a strong network with medical institutions and adopting protocols for high quality sample handling will facilitate the integration of IMGGE into the European initiative to build a biobank network. State-of-the-art methodologies in biomedical studies and RD biobanks will set up the basis for functional studies of human mutations. This will enable the identification of potential targets, which, in collaboration with an SME, will lead to designing cost-effective diagnostic test kit(s), pushing IMGGE towards innovations, and paving the path to the application of genome-based medicine. The local network to be established, NIRBOS (Research Initiative for RD in Serbia or Naucna Inicijativa za Retke Bolesti u Srbiji, in Serbian), will facilitate the dissemination and exploitation of the SERBORDISinn results. NIRBOS will also provide long-term sustainability of the Project. The implementation of SERBORDISinn will have an impact on unlocking and developing IMGGE’s research and innovation potential, improving public health in Serbia, strengthening cooperation with local partners, as well as Balkan and EU research institutions. SERBORDISinn activities will lead to the establishment of a high proficiency expert centre for MG studies of RD in IMGGE and to the real integration of IMGGE into the ERA.

Keywords: biomedical science,molecular genetics,rare diseases,biobank,unlocking research potential,innovation,serbia
CENTRE OF MOLECULAR BIOTECHNOLOGY FOR HEALTHY LIFE Biotech solutions bringing health to living organisms and environment supported by mass spec-focused research platform. (MOBI4HEALTH)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Poland
Call:  (FP7-REGPOT-2012-2013-1, 2012)
Start date: 2013-06-01
End date: 2016-11-30
Duration (months): 42.0
Total project cost (EUR): 5199952.06
EU funding (EUR): 4667006.0
Participants: 1
Project status: CLOSED

MOBI4HEALTH is intended to support the Intercollegiate Faculty of Biotechnology University of Gdansk & Medical University of Gdansk (IFB) in its activities to boost its research and innovation potential through establishing a Centre of Molecular Biotechnology for Healthy Life: MOBI4HEALTH Centre. IFB, founded in 1993, is one of the top three biological science faculties in Poland. Basic and applied research performed its research units cover the areas of molecular biotechnology, biomedicine and environment protection. The project is in line with IFB’s strategy, which is to adapt the research potential and existing excellence of the IFB to the current and future needs of the human & environmental health sector and knowledge-based economy. MOBI4HEALTH Centre will use collaboration with 10 partners from UK, France, Germany, Italy, Greece and Spain to achieve improved research capacity through: •employment of new experienced researchers and specialists for the mass spec core facility, •acquisition of mass spec equipment to ensure future cutting-edge research, •significant increase of scientific expertise through intensified international cooperation with leading European partners, •dissemination of skills acquired through twinning & networking activities in form of hands-on courses and workshops as well as dissemination of MOBI4Health project results at two international conferences that will target local/regional stakeholders in order to strengthen links with pharmaceutical companies, entrepreneurs, health professionals, policy-makers and media. •the implementation of an IP & Innovation Strategy with the goal of enhancing the ability of research staff to commercialize research achievements ensuring proper IP protection. This action plan will ensure that MOBI4HEALTH Centre can deliver sustainable innovative science based on advanced mass spec applications, future research interactions and long-lasting cooperation at regional and European level.

Keywords: molecular biotechnology,human health environmental health,mass spectrometry,proteomics,lipidomics,genomics
Israel Researchers' Night 2012 (IRN2012)

Framework: FP7 — People
Programme: Marie-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: European Researchers' Night
Action type: Coordination and support actions
Countries involved: Israel
Call:  (FP7-PEOPLE-2012-NIGHT, 2012)
Start date: 2012-05-01
End date: 2012-11-30
Duration (months): 7.0
Total project cost (EUR): 358790.4
EU funding (EUR): 145000.0
Participants: 10
Project status: CLOSED

Over 6 years of experience with Researchers' Night project and many more of engaging youngsters to science and scientists thought us that the more personal we make the event the more effective it will be on the long terms. In Researchers' Night 2012 we will try to make it moving, touching and unique by all means. Scientists will wear special shirts or badges to be easily identified and will call the public to talk, ask, interview, discuss issues with them. Some of them will be involved in scientific "missions" with the public to increase communication and cooperation. Many other interactive activities will take place involving scientists and the public alike to achieve the important targets of the Researchers' Night project. This year, the IRN2012 partners - a network of universities, colleges, science museums and science parks, many of whom worked together on Researchers' Night in previous years, will cover Israel from north to south and from west to east, with many opportunities for the public to connect with the researchers in their own locations. The event will comprise face-to-face meetings with scientists, science cafes and small group discussions with scientists about their scientific activities and lives. Given the extended countrywide activities, we anticipate a greater number of participants. Read on for details...

Keywords: people,reseachers,reseachers',night,israel,2012
European research centre of Network intelliGence for INnovation Enhancement (ENGINE)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Poland
Call:  (FP7-REGPOT-2012-2013-1, 2012)
Start date: 2013-06-01
End date: 2016-11-30
Duration (months): 42.0
Total project cost (EUR): 4731186.8
EU funding (EUR): 4245000.0
Participants: 1
Project status: CLOSED

The ENGINE Centre is an interdisciplinary research unit of the Wrocław University of Technology, specializing in so-called Network Intelligence. This term spans the development of innovative, intelligent and advanced tools for effective computing, smart decisions and intelligent human-computer interactions applied in medicine, natural sciences, sociology and psychology, management and economics, mobile entertainment, business and industrial solutions, with special emphasis on SMEs. Despite quite substantial funds allocated in the last years to the ENGINE Centre, its organizational and scientific level has not been attained yet comparable to that of leading research institutions in the European Research Area, first of all due to insufficient funds, lack of adequate staff trainings and unsatisfactory collaboration with external scientific and industrial partners. The crucial idea behind the ENGINE project is to significantly enhance the research potential of the ENGINE Centre by employment of new external reputed researchers, upgrading the laboratory’s equipment, and strengthening the know-how exchange of advanced and innovative research on networked intelligence. The main objectives of the ENGINE project are: (i) enhancement of staff abilities, (ii) better integration with ERA, (iii) improvement of existing technical capabilities, (iv) strengthening the long-lasting partnership with European research centres. The ENGINE project will also ensure to establish strong and lasting collaboration with industrial and governmental partners, including SMEs, for mutual benefits resulting in knowledge transfer and competitive future in cutting-edge scientific activities. The project will also help to achieve the sustainable development of the ENGINE Centre research quality, competitiveness and attractiveness, at the regional, national, European and worldwide level.

Keywords: academia-industry cooperation,artificial intelligence,computer science,data analysis,data mining,hci,innovation,interdisciplinary studies,network intelligence,machine learning,sme
Improving Biomedical Research and Innovation in the Canary Islands (IMBRAIN)

Framework: FP7 — Capacities
Programme: Research Potential
Destination: Unlocking and developing the Research Potential of research entities established in the EU�s Convergence regions and Outermost Regions
Action type: Coordination and support actions
Countries involved: Spain
Call:  (FP7-REGPOT-2012-2013-1, 2012)
Start date: 2012-12-01
End date: 2016-05-31
Duration (months): 42.0
Total project cost (EUR): 4619714.8
EU funding (EUR): 4158874.0
Participants: 1
Project status: CLOSED

To unlock and develop the research and innovation potential of the Centre for Biomedical Research of the Canary Islands (CIBICAN), a coherent series of activities have been designed through the development of this project (IMBRAIN). From a recent SWOT analysis, several impediments have been identified that must be overcome to maximize our research capacities. They include the isolation from decision−making centers and resources, the excessive cost and effort required to coordinate and collaborate in projects and to disseminate research achievements both into the science community and the society. In addition, despite the quality of the research teams and their focus on priority areas, the problems of recruiting experienced new researchers, technical staff and innovation managers remain a serious handicap that we are strongly committed to overcome. The main strategic objective of this project is to increase the quality of research at CIBICAN, and to build its innovation capacity to become a leading centre in Biomedicine and the Health Sciences. It will have a significant impact in promoting regional economic and social development, and in spreading of health knowledge into the outermost EU regions and the near African countries. This will be achieved through the following measures: 1) Exchange of know-how and experience with EU research partnering organizations; 2) Recruitment of experienced researchers, technical staff and innovation manager; 3) Upgrading of research equipment, based on existing infrastructure and core facilities; 4) Elaboration of a strategic IP development plan for IP management and protection and innovation capability building; 5) Dissemination of knowledge on health and increase the visibility of CIBICAN activities at regional, national and European levels. In addition, an ex−post evaluation facility will be developed at the end of the project to define specific strategy actions for long−term sustainable development.

Keywords: biomedical research,health science,biotechnology transfer,human diseases,innovation,ip rights